2-Methoxyethanol

2-Methoxyethanol

SCHEMBL3548931

C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.COCCO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
THRB P10828 1/20 0.31
HTT P42858 1/20 0.31
MAPT P10636 1/20 0.31
GBA1 P04062 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Methoxyethanol SCHEMBL145211 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL2915239 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL19086860 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL851952 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL17351933 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL1482714 1.00
2-Methoxyethanol SCHEMBL17351943 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL6268627 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL21641729 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A
2-Methoxyethanol SCHEMBL5091016 1.00 TSHR (0.41) TSHRMAPK1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118974864-A Electrolytic capacitor 松下知识产权经营株式会社 2024-11-15 CN claimed
CN-112736280-B Slurry, all-solid battery, and method for producing all-solid battery 丰田自动车株式会社 2024-05-14 CN claimed
US-11837721-B2 Slurry, all solid state battery and method for producing all solid state battery TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2023-12-05 US claimed
CN-112898452-A Hydrophilic antifogging polyolefin material and preparation method and application thereof 中国科学院化学研究所 2021-06-04 CN claimed
US-20150367277-A1 Alkanolamine-Based Carbon Dioxide Absorbent Containing Polyalkylene Glycol Monomethyl Ether, and Carbon Dioxide Absorption Method and Separation Method Using Same UNIVERSITY-INDUSTRY COOPERATION FOUNDATION OF KYUNG HEE UNIVERSITY (KR) 2015-12-24 US claimed
CN-118974864-A Electrolytic capacitor 松下知识产权经营株式会社 2024-11-15 CN disclosed
US-12095080-B2 Slurry, all solid state battery and method for producing all solid state battery TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2024-09-17 US disclosed
CN-116178117-B Fluoroether and preparation method thereof, electrolyte, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2024-09-06 CN disclosed
CN-118085147-A Polymer, preparation method thereof, all-solid-state polymer-inorganic ceramic composite electrolyte containing polymer and lithium battery 博研嘉信(北京)科技有限公司 2024-05-28 CN disclosed
CN-112736280-B Slurry, all-solid battery, and method for producing all-solid battery 丰田自动车株式会社 2024-05-14 CN disclosed
CN-114555707-B Fluoroether composition, coating liquid, article, method for producing same, and compound AGC株式会社 2024-04-23 CN disclosed
US-20240047658-A1 SLURRY, ALL SOLID STATE BATTERY AND METHOD FOR PRODUCING ALL SOLID STATE BATTERY TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2024-02-08 US disclosed
WO-2003022210-A2 PHARMACEUTICAL COMPOSITIONS OF DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH NOBEX CORPORATION (US) 2003-03-20 WO disclosed
WO-2003022208-A2 PHARMACEUTICAL COMPOSITIONS OF INSULIN DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH NOBEX CORPORATION (US) 2003-03-20 WO disclosed
US-6437124-B1 XANTHINE DERIVATIVES WHICH INHIBIT EXPRESSION OF ADHESION MOLECULES ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELL (HUVEC) MONOLAYERS AT VERY LOW CONCENTRATIONS SMITHKLINE BEECHAM CORPORATION 2002-08-20 US disclosed
US-6355646-B1 IMMUNOLOGY TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS SEPTIC SHOCK GLAXO WELLCOME INC. 2002-03-12 US disclosed
EP-0970081-A1 SUBSTITUTED (1,3-BIS(CYCLOHEXYLMETHYL)-1,2,3,6-TETRAHYDRO-2,6-DIOXO-9H-PURIN-8-YL)PHENYL DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS GLAXO GROUP LIMITED (GB) 2000-01-12 EP disclosed
WO-1998035966-A1 SUBSTITUTED (1,3-BIS(CYCLOHEXYLMETHYL)-1,2,3,6-TETRAHYDRO-2,6-DIOXO-9H-PURIN-8-YL)PHENYL DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF INFLAMMATORY CONDITIONS AND IMMUNE DISORDERS GLAXO GROUP LIMITED (GB) 1998-08-20 WO disclosed
US-4407810-A TREATMENT OF ALLERGIC DISORDERS BASF AKTIENGESELLSCHAFT (DE) 1983-10-04 US disclosed
US-3953510-A Method for the preparation of alkoxyanilines OLIN CORPORATION (US) 1976-04-27 US disclosed